Enorama Pharma AB (OSTO:ERMA) Cyclically Adjusted Book per Share: kr0.93 (As of Mar. 2026)


OSTO:ERMA Enorama Pharma AB OSTO:ERMA
29 GF Score
Price kr0.26
GF Value kr0.41
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Enorama Pharma AB Cyclically Adjusted Book per Share?

Enorama Pharma AB OSTO:ERMA -4.14% 29 Cyclically Adjusted Book per Share is kr0.93 as of Mar. 2026. GuruFocus rates OSTO:ERMA with a GF Score™ of 29/100 and a GF Value™ of kr0.41 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Enorama Pharma AB's adjusted book value per share for the three months ended in Mar. 2026 was kr-0.491. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.93 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Enorama Pharma AB's average Cyclically Adjusted Book Growth Rate was -12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-11), Enorama Pharma AB's current stock price is kr0.255. Enorama Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr0.93. Enorama Pharma AB's Cyclically Adjusted PB Ratio of today is 0.27.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Enorama Pharma AB was 3.98. The lowest was 0.27. And the median was 2.36.


Enorama Pharma AB  (OSTO:ERMA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enorama Pharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.255/0.93
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Enorama Pharma AB was 3.98. The lowest was 0.27. And the median was 2.36.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Enorama Pharma AB Cyclically Adjusted Book per Share Related Terms


Enorama Pharma AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Enorama Pharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enorama Pharma AB Cyclically Adjusted Book per Share Chart

Enorama Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.08 0.96

Enorama Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.04 1.01 0.96 0.93

OSTO:ERMA vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Enorama Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enorama Pharma AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enorama Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enorama Pharma AB's Cyclically Adjusted PB Ratio falls into.


OSTO:ERMA
29GF Score
Enorama Pharma AB OSTO:ERMA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enorama Pharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Enorama Pharma AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.491/133.5600*133.5600
=-0.491

Current CPI (Mar. 2026) = 133.5600.

Enorama Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.111 101.019 2.791
201609 1.916 101.138 2.530
201612 1.583 102.022 2.072
201703 1.307 102.022 1.711
201706 0.982 102.752 1.276
201709 0.605 103.279 0.782
201712 1.208 103.793 1.554
201803 0.712 103.962 0.915
201806 0.195 104.875 0.248
201809 0.296 105.679 0.374
201812 2.596 105.912 3.274
201903 1.901 105.886 2.398
201906 1.269 106.742 1.588
201909 2.129 107.214 2.652
201912 1.049 107.766 1.300
202003 0.378 106.563 0.474
202006 0.105 107.498 0.130
202009 0.126 107.635 0.156
202012 0.243 108.296 0.300
202103 0.410 108.360 0.505
202106 0.000 108.928 0.000
202109 0.338 110.338 0.409
202112 2.245 112.486 2.666
202203 1.091 114.825 1.269
202206 -0.070 118.384 -0.079
202209 -0.983 122.296 -1.074
202212 2.724 126.365 2.879
202303 0.675 127.042 0.710
202306 0.398 129.407 0.411
202309 0.431 130.224 0.442
202312 0.386 131.912 0.391
202403 0.345 132.205 0.349
202406 0.641 132.716 0.645
202409 0.558 132.304 0.563
202412 0.129 132.987 0.130
202503 0.154 132.825 0.155
202506 0.123 133.699 0.123
202509 -0.062 133.480 -0.062
202512 -0.314 133.390 -0.314
202603 -0.491 133.560 -0.491

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr0.93 mean?
Enorama Pharma AB (OSTO:ERMA) has a Cyclically Adjusted Book per Share of kr0.93 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Enorama Pharma AB and its competitors.
Is Enorama Pharma AB's Cyclically Adjusted Book per Share too high?
Enorama Pharma AB's current Cyclically Adjusted Book per Share is kr0.93. Overall, Enorama Pharma AB has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enorama Pharma AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Enorama Pharma AB's Cyclically Adjusted Book per Share of kr0.93 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Enorama Pharma AB and its competitors. Enorama Pharma AB's current Cyclically Adjusted Book per Share is kr0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enorama Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, Enorama Pharma AB (OSTO:ERMA) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.41, compared to a current price of kr0.26 — trading 37.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is kr0.93. Enorama Pharma AB's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Enorama Pharma AB (OSTO:ERMA), the current Cyclically Adjusted Book per Share is kr0.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enorama Pharma AB (OSTO:ERMA) Overvalued in 2026?

Based on GuruFocus' analysis, Enorama Pharma AB stock appears to be undervalued. The current stock price of kr0.26 is trading 37.8% below its estimated GF Value™ of kr0.41. GuruFocus considers Enorama Pharma AB to be Possible Value Trap.

Key valuation signals for OSTO:ERMA:

  • Cyclically Adjusted Book per Share: kr0.93
  • GF Value™: kr0.41 vs. price of kr0.26 (37.8% below fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the OSTO:ERMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enorama Pharma AB Business Description

Address Vastra Varvsgatan 19, Malmo, SWE, SE-211 77
Enorama Pharma AB is a pharmaceutical company that focuses on consumer-friendly medicated chewing gum containing generic substances. It provides medicated gums containing generic pharmaceutical substances, developed through its ChewMed technology platform.
29GF Score

Get the complete analysis for OSTO:ERMA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.26
Price
kr0.41
GF Value